Completed
A Study to Assess the Safety and Efficacy of Ruxolitinib Cream in Participants With Genital Vitiligo
NCT05750823
- Conditions
- Hypopigmentation, Nonsegmental Vitiligo With Genital Involvement, Pigmentation Disorders, +3 more
- Locations
-
- Center For Dermatology Clinical Research, Inc Fremont, California, United States
- Vitiligo & Pigmentation Institute of Southern California Los Angeles, California, United States
- Hamzavi Dermatology Fort Gratiot, Michigan, United States
- Apex Clinical Research Center Mayfield, Ohio, United States